Arcutis Biotherapeutics Inc (ARQT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ARQT Giù? Forum Previsione

Arcutis Biotherapeutics Inc Azioni (ARQT) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	266.47% 49.57	13.53	38.11	5.19	2.781
Cost Of Revenue	3.256	-	-	-	-
Gross Profit	46.31	-	-	-	-
Operating Expenses	11.80% 77.94	69.71	75.01	71.95	79.05
Interest Income/Expense	3.63% 7.48	7.762	7.559	7.349	7.042
Benefits Costs and Expenses	73.00% 81.19	300.71	-	-	-
Costs And Expenses	8.70% 81.19	74.69	75.01	71.95	79.05
Operating Income/Loss	48.30% -31.62	-61.17	-36.90	-66.76	-76.27
Income/Loss From Continuing Operations Before Tax	88.99% -31.62	-287.18	38.11	-70.99	-80.10
Income Tax Expense/Benefit	1,196% 0.324	0.025	3.023	-	-
Income/Loss From Continuing Operations After Tax	46.62% -35.38	-66.28	-44.77	-70.99	-80.10
Net Income/Loss	46.62% -35.38	-66.28	-44.77	-70.99	-80.10
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,316% 111.05	7.8435	61.73	61.43	61.17
Diluted Average Shares	1,316% 111.05	7.8435	61.73	61.43	61.17
Basic Earnings Per Share	45.76% -0.32	-0.59	-0.73	-1.16	-1.31
Diluted Earnings Per Share	45.76% -0.32	-0.59	-0.73	-1.16	-1.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%